Last A$0.0080 AUD
Change Today 0.00 / 0.00%
Volume 698.2K
PAA On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:53 PM 03/2/15 All times are local (Market data is delayed by at least 15 minutes).

pharmaust ltd (PAA) Snapshot

Open
A$0.0080
Previous Close
A$0.0080
Day High
A$0.0080
Day Low
A$0.0070
52 Week High
03/6/14 - A$0.02
52 Week Low
01/29/15 - A$0.0060
Market Cap
11.5M
Average Volume 10 Days
2.3M
EPS TTM
A$-0.0015
Shares Outstanding
1.4B
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PHARMAUST LTD (PAA)

Related News

No related news articles were found.

pharmaust ltd (PAA) Related Businessweek News

No Related Businessweek News Found

pharmaust ltd (PAA) Details

PharmAust Limited, through its subsidiaries, operates as a drug discovery and development company primarily in Australia and Switzerland. It provides products and services in synthetic and medicinal chemistry on a contract basis for the drug discovery and pharmaceutical industries. The company’s products include a range of pharmaceutical impurities, degradants, and metabolites of active ingredients and excipients primarily for OTC and generic drugs. It also focuses on developing a drug discovery intellectual property for the treatment of various types of cancers in humans and animals. The company is based in Nedlands, Australia.

4 Employees
Last Reported Date: 08/27/14

pharmaust ltd (PAA) Top Compensated Officers

Executive Chairman
Total Annual Compensation: A$231.7K
Executive Director
Total Annual Compensation: A$69.3K
Compensation as of Fiscal Year 2014.

pharmaust ltd (PAA) Key Developments

PharmAust Limited Announces Consolidated Earnings Results for the Half Year Ended December 31, 2014

PharmAust Limited announced consolidated earnings results for the half year ended December 31, 2014. For the period, the company reported revenues of AUD 808,790 compared with AUD 910,175 for the same period a year ago. Loss before income tax was AUD 1,073,366 compared with AUD 639,984 for the same period a year ago. Loss for the period was AUD 1,073,366 or 0.07 cents per basic and diluted share compared with AUD 639,984 or 0.05 cents per basic and diluted share for the same period a year ago. Net cash used in operating activities was AUD 1,048,745 compared with AUD 1,272,634 for the same period a year ago. Payment for plant and equipment was AUD 111,303 compared with AUD 101,695 for the same period a year ago.

PharmAust Limited, Annual General Meeting, Oct 24, 2014

PharmAust Limited, Annual General Meeting, Oct 24, 2014.

PharmAust Limited Reports Consolidated Earnings Results for the Year Ended June 30, 2014

PharmAust Limited reported consolidated earnings results for the year ended June 30, 2014. For the period, the company's revenue was AUD 1,880,793 compared to AUD 1,616,569 a year ago. Loss before income tax expense was AUD 1,317,853 compared to AUD 639,167 a year ago. Loss for the year was AUD 1,317,853 or 0.1 cents per basic and diluted share compared to AUD 514,883 or 0.09 cents per basic and diluted share a year ago. Net cash used in operating activities was AUD 1,588,355 compared to AUD 305,460 a year ago. Payments for plant and equipment were AUD 73,304 compared to AUD 11,496 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PAA:AU A$0.01 AUD 0.00

PAA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PAA.
View Industry Companies
 

Industry Analysis

PAA

Industry Average

Valuation PAA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.3x
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMAUST LTD, please visit www.pharmaust.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.